Skip to main content
hello world

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Regulus Therapeutics to Participate in Upcoming Investor Conferences

PR Newswire - Fri Sep 2, 2022

SAN DIEGO, Sept. 2, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. ( Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that the Company will participate in two upcoming investor conferences.

Read more at prnewswire.com